Companies: 10,795·Total market cap: $144.5T
Nutex Health, Inc.

Nutex Health, Inc.

NUTXNASDAQHealthcare● Active
$134.41
+$1.82(+1.37%)
Market Cap$800320958
P/E Ratio
52W High$193.07
52W Low$77.21

Nutex Health, Inc. (NUTX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · NUTX · as of Jun 8, 2026

Activity summary

Buy transactions

5

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Nutex Health, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

NUTX insider buying and selling by quarter

NUTX insider selling · NUTX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
577K288K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · NUTX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

NUTX executive sell shares · NUTX board member insider trading · NUTX insider trading SEC filing

Showing 55 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Spears Kelvin

Director

Other

Date

Jun 4

Shares

2,519

Price

Value

View Form 4 on SEC.gov

Vo Thomas T.

CEO · Director

Other

Date

May 28

Shares

75,747

Price

Value

View Form 4 on SEC.gov

Vo Thomas T.

CEO · Director

Other

Date

Apr 9

Shares

184,071

Price

Value

View Form 4 on SEC.gov

Hosseinion Warren

President · Director

Purchase

Date

Mar 19

Shares

252

Price

$94.07

Value

$24K

View Form 4 on SEC.gov

Jaumot Frank E

Director

Purchase

Date

Mar 20

Shares

150

Price

$93.56

Value

$14K

View Form 4 on SEC.gov

Spears Kelvin

Director

Purchase

Date

Mar 17

Shares

10

Price

$94.46

Value

$945

View Form 4 on SEC.gov

Montgomery Pamela W.

Chief Legal Officer-Healthcare

Purchase

Date

Mar 13

Shares

79

Price

$88.87

Value

$7K

View Form 4 on SEC.gov

Luqman Elisa V

Chief Legal Officer - SEC

Option

Date

Mar 10

Shares

2,084

Price

Value

View Form 4 on SEC.gov

Luqman Elisa V

Chief Legal Officer - SEC

Other

Date

Mar 10

Shares

784

Price

$86.22

Value

$68K

View Form 4 on SEC.gov

Montgomery Pamela W.

Chief Legal Officer-Healthcare

Option

Date

Mar 10

Shares

2,084

Price

Value

View Form 4 on SEC.gov

Montgomery Pamela W.

Chief Legal Officer-Healthcare

Other

Date

Mar 10

Shares

776

Price

$86.22

Value

$67K

View Form 4 on SEC.gov

Spears Kelvin

Director

Option

Date

Mar 10

Shares

183

Price

Value

View Form 4 on SEC.gov

Spears Kelvin

Director

Other

Date

Mar 10

Shares

82

Price

$86.22

Value

$7K

View Form 4 on SEC.gov

Chang Michael L.

Chief Medical Officer

Option

Date

Mar 10

Shares

2,084

Price

Value

View Form 4 on SEC.gov

Chang Michael L.

Chief Medical Officer

Other

Date

Mar 10

Shares

769

Price

$86.22

Value

$66K

View Form 4 on SEC.gov

Hosseinion Warren

President · Director

Option

Date

Mar 10

Shares

6,293

Price

Value

View Form 4 on SEC.gov

Hosseinion Warren

President · Director

Other

Date

Mar 10

Shares

3,274

Price

$86.22

Value

$282K

View Form 4 on SEC.gov

Vo Thomas T.

CEO · Director

Option

Date

Mar 10

Shares

8,334

Price

Value

View Form 4 on SEC.gov

Vo Thomas T.

CEO · Director

Other

Date

Mar 10

Shares

3,017

Price

$86.22

Value

$260K

View Form 4 on SEC.gov

Bates Jon Christian

CFO

Option

Date

Mar 10

Shares

2,667

Price

Value

View Form 4 on SEC.gov

Bates Jon Christian

CFO

Purchase

Date

Nov 25

Shares

750

Price

$136.71

Value

$103K

View Form 4 on SEC.gov

Bates Jon Christian

CFO

Purchase

Date

Apr 8

Shares

1,000

Price

$81.81

Value

$82K

View Form 4 on SEC.gov

Bates Jon Christian

CFO

Option

Date

Mar 1

Shares

1,500

Price

Value

View Form 4 on SEC.gov

Bates Jon Christian

CFO

Option

Date

Mar 1

Shares

111

Price

Value

View Form 4 on SEC.gov

Spears Kelvin

Director

Option

Date

Mar 1

Shares

143

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About NUTX insider trading

NUTX insider trades

Nutex Health, Inc. (NUTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Spears Kelvin (Director), Vo Thomas T. (CEO · Director), Hosseinion Warren (President · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. NUTX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Nutex Health, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

NUTX insider trading · 5 questions

The insiders of Nutex Health, Inc. (NUTX) include executives and directors such as Spears Kelvin (Director), Vo Thomas T. (CEO · Director), Hosseinion Warren (President · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

NUTX board member insider tradingwho are NUTX insidersNUTX insider rosterNutex Health, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026